As a fully digital three-day event, Digital ILC 2020 brought together thousands of delegates from all over the world. EASL invited you, the delegates, to take part in the first ever EASL Share competition. We asked you to submit creative entries, anything from an image, drawing, or a piece of you…
On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease. Scientists, practitioners, and patient advocates discussed two EASL Policy S…
Save the date and register for the first webinar. Free access. Topic: Sarcopenia in chronic liver disease When: Thursday, 12th Nov. 2020 from 8 pm to 9.30 pm CET Learning objectives: To gain an understanding of the pathophysiology of sarcopenia and the impact this has on people with CLD To review…
AMRA Medical Research Results Support Strengthening Sarcopenia Guidelines AMRA Medical’s research publication in JHEP Reports details the link between MRI-based adverse muscle composition and NAFLD metabolic comordidity & poor function. Linköping, Sweden, October 28, 2020 AMRA’s research, in coll…
From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster the next generation of bright minds. Are you a young scientist on a dynamic career path in hepatology? Are you exploring the next challeng…
5 October 2020 The Nobel Prize in Physiology or Medicine 2020 has been awarded jointly to Harvey J. Alter, Michael Houghton, and Charles M. Rice for the discovery of hepatitis C virus The 2020 Nobel Prize for Physiology and Medicine was awarded to Harvey Alter, Michael Houghton, and Charles Rice …
An international study led by researchers at Oxford University Hospitals NHS Foundation Trust has shown that patients with cirrhosis are at increased risk of dying as a result of COVID-19. Oxford, October 6, 2020 – The study, published in the Journal of Hepatology found that mortality from COVID-…
19 September 2020 EASL is part of a joint initiative on the impact of COVID-19 on liver transplantation, aiming to explore how patients, healthcare professionals, and liver transplant centres across the world are affected – in their clinical care and waiting-list management. To this end, a survey…
This week, 7-13 September, marks the 2020 Global Week for Action on NCDs (non-communicable diseases). The campaign draws on energy, inspiration, determination, optimism, and outrage to focus efforts on ensuring NCD prevention and control get the attention and action they deserve from governments….
It is with great sadness that EASL announces the passing of Prof. Christiaan Hendrik (Chris) Gips, a pioneer in liver transplantation, patient empowerment, and education in the field of hepatology. His work was characterised by great vision and intelligence. Prof. Gips studied medicine in Leiden,…
